Abstract
PLACENTAL MESENCHYMAL DYSPLASIA: RARE CASE OF NORMAL FETUS ASSOCIATED WITH INTRAUTERINE GROWTH RESTRICTION AND OLIGOHYDRAMINOUS

Dr. Sharif Jamal Hamed Salha* and Dr. Madleen Jawad Sobhe Abu Aser

ABSTRACT

Background: Placental mesenchymal dysplasia (PMD) Placental mesenchymal dysplasia (PMD) is a rare, benign placental, vascular anomaly. PMD is characterized by placentomegaly and grape-like vesicles resembling molar pregnancy on ultrasonography (USG). The differential diagnosis of PMD includes partial molar pregnancy, complete mole with the coexisting normal fetus, chorioangioma, subchorionic hematoma, and spontaneous abortion with hydropic changes. Prenatal recognition of PMD during early and late gestation could prevent unnecessary termination of pregnancy. Is an uncommon vascular anomaly of the placenta characterized by placentomegaly with a multicystic placental lesion on ultrasonography and mesenchymal stem villous hyperplasia on histopathology, Anan et al (2015). Placental mesenchymal dysplasia should be considered in the differential diagnosis of cases of multicystic placental lesions such as molar pregnancy, chorioangioma, subchorionic hematoma, and spontaneous abortion with hydropic placental changes. However, the lack of high-velocity signals inside the lesion and a normal karyotype favor a diagnosis of PMD. PMD must be differentiated from gestational trophoblastic disease because management and outcomes differ. PMD is an uncommon illness characterized by placentomegaly and aberrant chorionic villi that is frequently misdiagnosed as partial hydatidiform mole. It is, nevertheless, clinic pathologically distinct from intrauterine growth limitation is very common. (IUGR) and the mortality of the fetus this research reveals new findings. PMD examples are discussed, as well as a meta-analysis of the research. IUGR and fetal death rates are linked.

Keywords: .


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MAY ISSUE PUBLISHED

    MAY 2024 Issue has been successfully launched on 1 MAY 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT